About the Cancer Registry
NO
Toggle navigation
About the Cancer Registry
Search
Toggle navigation
NO
The Registries
Cancer Statistics
Data and statistics
Incidence
Statistics online
Clinical Registries
Norwegian Colorectal Cancer Registry
Kvalitetsmål for Tykk- og endetarmskreftregisteret
Tykk- og endetarmskreftregisterets fagråd
Resultater fra Tykk- og endetarmskreftregisteret
Dekningsgrad og datakvalitet i Tykk- og endetarmskreftregisteret
Data delivery unit
Contents of database
Molekylære markører
Billing procedures
Disclaimer
Research
News & Events
RNA forum
Departments and reseachers
Section for integrative genomics
Section for Epidemiology and Prevention
Projects
Nordpred: Prediction of cancer incidence in the Nordic countries up to the year 2020
Nordpred software package
A randomized study on colorectal cancer screening (NORCCAP)
NORCCAP - Ph.D theses
NORCCAP - publications
Rådgivingsgruppe NORCCAP-biobank
Physical activity, fitness and cancer
JanusRNA - identification of early cancer biomarkers
miRNA signaturer i pasienter med kreft i tykktarm, bryst og lunge
Biomarkers of Cancer: Biocomputional analysis of data from population-based biobanks and health registries
Sequencing HPV for biomarker discovery
Intra-patient HPV genetic variation
HPV genomic workshop
Cancer and pregnancy
Vitamin D, obesity and cutaneous malignant melanoma
The microbiome as a colorectal cancer screening biomarker (CRCbiome)
Sammenheng mellom bearbeidet mat og tarmkreft
Mikrobiella biomarkører - NORCCAP
Deltakerinformasjon CRCbiome
Masterprosjekter
Prescribed drugs and cutaneous melanoma
Cancer among Norwegian offshore workers
Spørreundersøkelse for kartlegging av yrkesrelatert sykdom blant norske offshorearbeidere
Exposure-related risks of cancer in petroleum workers
Publications Offshore
Benzene-related risk of cancer among Norwegian offshore workers
Cohorts offshore workers
Overdiagnosis and underdiagnosis in BreastScreen Norway
Machine Learning in BreastScreen Norway
Tomosynthesis – the future screening tool for breast cancer?
How likely are benign breast disease and premalignant lesions to progress to invasive breast cancer?
Personalizing colorectal cancer screening by lifestyle
New cancer treatment and survival
Immunotherapy and targeted therapy of advanced non-small cell lung carcinoma
Effectiveness of tomosynthesis in breast cancer screening
Long-term effects following treatment of screen-detected versus symptomatic breast cancer
Can artificial intelligence increase accuracy and effectiveness of breast cancer screening?
How quickly do breast cancers grow?
Cancer patient pathways in Norway
SARS-CoV-2 in cancer patients
ImmigrantScreen
BADDI: Artificial intelligence in screening with standard mammography and tomosynthesis
Patient reported outcomes after treatment for colorectal cancer – A prospective nationwide study from The Norwegian Colorectal Cancer Registry
Scientific publications
List of publications 2016
Under 30 forfattere
Over 30 forfattere
List of publications 2015
Artikler under 30 forfattere
Artikler over 30 forfattere
List of publications 2014
List of publications 2013
List of publications 2012
List of publications 2011
List of publications 2010
List of publications 2009
List of Publications 2008
Published articles 2017
First and/or last author
All published articles 2017
Published articles 2018
First and/or last author
All published articles
Published articles 2019
first and/or last author
All published articles
Published articles 2020
All published articles
First and/or last author
Published articles 2021
Janus Serum Bank
Research and project handling
Published articles
How to apply for serum samples
Søknadsskjema
Study design
Project organization
Publications
Priser for bruk av serumprøver og data
Sample and data prices
Biologisk materiale og data fra Janus serumbank
The Janus material
Age at first sample
News
Quality assurance
Stability data
Prøvekvalitet
Cancer Statistics
Screening
About the national screening programmes
Fact sheets in English, Arabic and Urdu
BreastScreen Norway
Breast Cancer Screening Programme
Ofte Stilte Spørsmål
About the programme
Samtykke
Tomosyntese – fremtidens screeningmetode for brystkreft?
Covid-19 and BreastScreen Norway
The screening mammogram
Benefits and harms
Diskusjon om nytteverdi
Om beregninger for brystkreftdødelighet og overdiagnostikk
More information about advantages and disadvantages of breast cancer screening
EU-TOPIA
Information material in BreastScreen Norway
Breast centres
Research in BreastScreen Norway
Om komprimert brysttykkelse
Om oppmøte
Om forekomst og overdiagnostikk
Om hormonbehandling
Om bruk av brystfantomer i testing
Om kompresjonskraft og stråledose i Mammografiprogrammet
Om kompresjonskraft i Mammografiprogrammet
Om prosessindikatorer og brystkompresjon
Artikkelomtaler 2014-2018
Cervical Cancer Screening in Norway
Frequently asked questions
HPV Vaccine
Ta livmorhalsprøve regelmessig. Hvor ofte er det?
HPV
Dette skjer når du tar livmorhalsprøve
Hva er celleforandringer
The PAP test
Benefits and harms of screening
Letters
Reservation
Nå kan Livmorhalsprogrammet dele prøvehistorikk
Vaccine
Cervical Cancer Screening Programme
ColorectalScreen Norway
Staff
Vacant positions
Media
Strategy
The Statistics bank
Cancer in Norway
Publications
Personvern
Key figures on cancer
Kreftformer
About the Cancer Registry
Search
Toggle navigation
NO
The Registries
Cancer Statistics
Data and statistics
Clinical Registries
Data delivery unit
Research
News & Events
Departments and reseachers
Projects
Scientific publications
Janus Serum Bank
Screening
About the national screening programmes
BreastScreen Norway
CervicalScreen Norway
ColorectalScreen Norway
Staff
The Statistics bank
Key figures on cancer
Vacant positions
Cancer in Norway
Kreftformer
Media
Publications
Strategy
Personvern
Home
•
General
General
About the Cancer Registry
News
Publications
General
